Author Question: A nurse is caring for a patient being treated for newly diagnosed irritable bowel syndrome. The ... (Read 69 times)

penguins · **on:** Jul 23, 2018

A nurse is caring for a patient being treated for newly diagnosed irritable bowel syndrome. The nurse should anticipate the administration of which muscarinic antagonist?

a. Bethanechol (Urecholine)
b. Pirenzepine and telenzepine
c. Physostigmine
d. Dicyclomine (Bentyl)

Question 2

A nurse is providing community education about medications and the drug schedules established by the U.S. Drug Enforcement Administration (DEA). Which statement made by a member of the class best demonstrates an understanding of DEA schedules?

a. Schedule I drugs have the lowest potential for abuse.
b. Schedule II drugs have no approved indications.
c. Schedule V drugs have the highest potential for abuse.
d. Schedule I drugs are not approved for any medical use.

abro1885 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

D
The nurse should administer dicyclomine, which is indicated for irritable bowel syndrome.
Bethanechol is a muscarinic agonist, not an antagonist, and would not be used to treat a patient with irritable bowel syndrome.
Pirenzepine and telenzepine are indicated for peptic ulcer disease, not irritable bowel syndrome.
Physostigmine is indicated for antimuscarinic poisoning.

Answer to Question 2

D
Schedule I drugs are not approved for any medical use.
Schedule I drugs have the highest potential for abuse.
Schedule II drugs have several approved indications.
Schedule V drugs have the lowest potential for abuse.